Electroporation based gene therapy--from the bench to the bedside

Area of Science:

• Biotechnology
• Molecular Biology
• Dermatology

Background:

• Effective transgene delivery is crucial for gene therapy.
• Electroporation is a viable method for DNA delivery.
• Skin is a promising target for gene transfer applications.

Purpose of the Study:

• Evaluate electroporation for skin gene transfer.
• Investigate applications in wound healing, DNA vaccines, and melanoma therapy.

Main Methods:

• Utilized electroporation for plasmid DNA delivery to skin.
• Administered plasmid DNA encoding vascular endothelial growth factor for wound healing.
• Delivered plasmid DNA encoding Hepatitis B surface antigen for vaccine studies.
• Injected plasmid DNA encoding cytokines directly into melanoma tumors followed by electroporation.

Main Results:

• Accelerated wound healing observed with vascular endothelial growth factor delivery.
• High antibody titers induced with Hepatitis B surface antigen DNA vaccine.
• Significant melanoma cell necrosis and IL-12 expression in Phase I trial.
• Observed lymphocytic infiltrate and systemic response in untreated lesions.

Conclusions:

• Electroporation is a powerful tool for skin gene transfer.
• Demonstrated potential in accelerating wound healing and cancer therapy.
• Shows promise for DNA vaccine development and clinical translation.